AORT
Price
$43.93
Change
+$0.12 (+0.27%)
Updated
Aug 29 closing price
Capitalization
2.07B
59 days until earnings call
BIAF
Price
$0.24
Change
-$0.00 (-0.00%)
Updated
Aug 29 closing price
Capitalization
6.89M
72 days until earnings call
Interact to see
Advertisement

AORT vs BIAF

Header iconAORT vs BIAF Comparison
Open Charts AORT vs BIAFBanner chart's image
Artivion
Price$43.93
Change+$0.12 (+0.27%)
Volume$342.98K
Capitalization2.07B
bioAffinity Technologies
Price$0.24
Change-$0.00 (-0.00%)
Volume$170.06K
Capitalization6.89M
AORT vs BIAF Comparison Chart in %
Loading...
AORT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BIAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AORT vs. BIAF commentary
Sep 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AORT is a Buy and BIAF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 01, 2025
Stock price -- (AORT: $43.93 vs. BIAF: $0.24)
Brand notoriety: AORT and BIAF are both not notable
AORT represents the Medical/Nursing Services, while BIAF is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: AORT: 75% vs. BIAF: 3%
Market capitalization -- AORT: $2.07B vs. BIAF: $6.89M
AORT [@Medical/Nursing Services] is valued at $2.07B. BIAF’s [@Medical Specialties] market capitalization is $6.89M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $230.89B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.64B. The average market capitalization across the [@Medical Specialties] industry is $10.68B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AORT’s FA Score shows that 0 FA rating(s) are green whileBIAF’s FA Score has 1 green FA rating(s).

  • AORT’s FA Score: 0 green, 5 red.
  • BIAF’s FA Score: 1 green, 4 red.
According to our system of comparison, AORT is a better buy in the long-term than BIAF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AORT’s TA Score shows that 3 TA indicator(s) are bullish while BIAF’s TA Score has 5 bullish TA indicator(s).

  • AORT’s TA Score: 3 bullish, 5 bearish.
  • BIAF’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, BIAF is a better buy in the short-term than AORT.

Price Growth

AORT (@Medical/Nursing Services) experienced а -2.01% price change this week, while BIAF (@Medical Specialties) price change was -4.53% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.77%. For the same industry, the average monthly price growth was +6.45%, and the average quarterly price growth was +9.91%.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.46%. For the same industry, the average monthly price growth was +7.37%, and the average quarterly price growth was +8.13%.

Reported Earning Dates

AORT is expected to report earnings on Oct 30, 2025.

BIAF is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Medical/Nursing Services (+0.77% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Medical Specialties (-0.46% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AORT($2.07B) has a higher market cap than BIAF($6.89M). AORT YTD gains are higher at: 53.655 vs. BIAF (-73.396). AORT has higher annual earnings (EBITDA): 39.8M vs. BIAF (-11M). AORT has more cash in the bank: 53.5M vs. BIAF (803K). BIAF has less debt than AORT: BIAF (670K) vs AORT (264M). AORT has higher revenues than BIAF: AORT (405M) vs BIAF (7.68M).
AORTBIAFAORT / BIAF
Capitalization2.07B6.89M30,078%
EBITDA39.8M-11M-362%
Gain YTD53.655-73.396-73%
P/E RatioN/AN/A-
Revenue405M7.68M5,273%
Total Cash53.5M803K6,663%
Total Debt264M670K39,403%
FUNDAMENTALS RATINGS
AORT: Fundamental Ratings
AORT
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
PROFIT vs RISK RATING
1..100
42
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
79
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AORTBIAF
RSI
ODDS (%)
Bearish Trend 4 days ago
71%
Bullish Trend 4 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
66%
Bullish Trend 4 days ago
86%
Momentum
ODDS (%)
Bullish Trend 5 days ago
72%
Bullish Trend 4 days ago
87%
MACD
ODDS (%)
Bearish Trend 4 days ago
67%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
65%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
78%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 14 days ago
83%
Declines
ODDS (%)
Bearish Trend 18 days ago
66%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
70%
Bullish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
77%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AORT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BIAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ETHSX12.900.05
+0.39%
Eaton Vance Worldwide Health Sci A
IICHX11.98-0.03
-0.25%
AMF Large Cap Equity H
FFNAX13.88-0.05
-0.36%
Fidelity Advisor Asset Manager 40% A
PJRCX8.81-0.04
-0.45%
PGIM Quant Solutions International Eq C
JMGZX47.82-0.48
-0.99%
JPMorgan Mid Cap Growth R2

AORT and

Correlation & Price change

A.I.dvisor indicates that over the last year, AORT has been loosely correlated with TCMD. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if AORT jumps, then TCMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AORT
1D Price
Change %
AORT100%
+0.27%
TCMD - AORT
43%
Loosely correlated
+1.06%
VREX - AORT
42%
Loosely correlated
+0.70%
LMAT - AORT
42%
Loosely correlated
+0.10%
SONVY - AORT
42%
Loosely correlated
+1.39%
SYK - AORT
41%
Loosely correlated
+0.45%
More